GT200000104A - POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. - Google Patents
POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS.Info
- Publication number
- GT200000104A GT200000104A GT200000104A GT200000104A GT200000104A GT 200000104 A GT200000104 A GT 200000104A GT 200000104 A GT200000104 A GT 200000104A GT 200000104 A GT200000104 A GT 200000104A GT 200000104 A GT200000104 A GT 200000104A
- Authority
- GT
- Guatemala
- Prior art keywords
- diclorhydrate
- polymorphes
- crystalline
- azobiciclo
- ilamine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- AKQZEFRALAUBFS-UHFFFAOYSA-N ilamine Natural products COC(C)C(O)(C(=O)OCC1=CCN2CCCC12)C(C)(C)O AKQZEFRALAUBFS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 AMINE DIHYDRATE Chemical class 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000005062 synaptic transmission Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
DOS FORMAS POLIMORFICAS CRISTALINAS DEL DICLORHIDRATO DE (2BENCIDRIL1AZOBICICLO [2.2.2]OCT3IL) (5 ISOPROPIL 2 METOXIBENCIL) AMINA DIHIDRATADO SON LA FORMA I Y LA FORMA II. LA COMPOSICION FARMACEUTICA QUE CONTIENE POR LO MENOS UNO DE ESTOS POLIMORFOS PRESENTA UNA ESTABILIDAD VENTAJOSA (EL COMPUESTO PURO ES HIDRATABLE) PARA PREPARAR UNA FORMULACION DESTINADA A TRATAR LA EMESIS EN PACIENTES QUE RECIBEN QUIMIOTERAPIA. LA ADMINISTRACION DE ESTA COMPOSICION FARMACEUTICA ES ORAL CONVENCIONAL, PREFERIBLEMENTE MEDIANTE COMPRIMIDOS O CAPSULAS, O INTRAVENOSA. EL COMPUESTO ES UN ANTAGONISTA DE RECEPTORES ACTIVOS NK 1 DEL SNC Y SE REFIERE AL TRATAMIENTO DE DOLENCIAS FACILITADAS POR UNA DISMINUCION DE LA NEUROTRANSMISION MEDIADA POR LA SUSTANCIA P.TWO CRYSTALLINE POLYMORPHIC FORMS OF THE (2BENCIDRIL1AZOBICICLO [2.2.2] OCT3IL) DICLORHYDRATE (5 ISOPROPIL 2 METOXIBENCIL) AMINE DIHYDRATE ARE FORM I AND FORM II. THE PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE OF THESE POLYMORPHES PRESENTS AN ADVANTAGE STABILITY (THE PURE COMPOUND IS HYDRATIONABLE) TO PREPARE A FORMULATION INTENDED TO TREAT EMESIS IN PATIENTS RECEIVING CHEMOTHERAPY. THE ADMINISTRATION OF THIS PHARMACEUTICAL COMPOSITION IS CONVENTIONAL ORAL, PREFERIBLY THROUGH COMPRESSED OR CAPSULES, OR INTRAVENOUS. THE COMPOUND IS AN ANCEGONIST OF ACTIVE RECEIVERS NK 1 OF THE SNC AND REFERS TO THE TREATMENT OF DOLENCES PROVIDED BY A DECREASE OF THE NEUROTRANSMISSION MEDIATION BY THE SUBSTANCE P.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GT200000104A GT200000104A (en) | 2000-06-28 | 2000-06-28 | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GT200000104A GT200000104A (en) | 2000-06-28 | 2000-06-28 | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200000104A true GT200000104A (en) | 2001-12-20 |
Family
ID=47043927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200000104A GT200000104A (en) | 2000-06-28 | 2000-06-28 | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. |
Country Status (1)
| Country | Link |
|---|---|
| GT (1) | GT200000104A (en) |
-
2000
- 2000-06-28 GT GT200000104A patent/GT200000104A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0954314T3 (en) | Dosage forms for ameliorating male erectile dysfunction | |
| DE60038183D1 (en) | COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | |
| AR025959A1 (en) | DERIVATIVES OF TER.-BUTIL- (7-METHYL-IMIDAZO [1,2, a] PIRIDIN-3-IL) -AMINA, PROCEDURE FOR THEIR PREPARATION, DRUGS THAT CONTAIN THEM, THEIR USE FOR THE PREPARATION OF A MEDICATION FOR THE INHIBITION OF NON-SYNTHEASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| GT199900203A (en) | CELECOXIB COMPOSITIONS. | |
| AR028833A1 (en) | INHIBITING METALOPROTEASE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USE FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHOD AND PROCEDURE FOR PREPARATION | |
| ES2091649T3 (en) | USE OF RIFAXIMINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT IN THE TREATMENT OF GASTRIC DYSPEPSIA CAUSED BY HELICOBACTER PYLORI. | |
| SV2002000696A (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS PC9985AHXK / BB | |
| CL2009001682A1 (en) | Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00). | |
| PA8465901A1 (en) | NEW DERIVATIVES OF ERYTHROMYCIN | |
| BR0015605A (en) | Composition and use | |
| AR024118A1 (en) | BICYCLE OXAZOLIDINONE COMPOUND AS ANTIBACTERIAL AGENTS, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| AR024411A1 (en) | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT-3-ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. | |
| ES2150404T3 (en) | PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITOZOXANIDA. | |
| AR035553A1 (en) | CRYSTAL FORMS OF MELAGATRAN, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL FORMULATION, AND USE OF THIS COMPOUND IN THE DEVELOPMENT OF MEDICINES. | |
| UY26176A1 (en) | POLYMORPHIC FORMS OF A AZOBICICLO CITRATE (2,2,2) OCTAN-3-AMINE AND ITS PHARMACEUTICAL COMPOSITIONS. | |
| GT200000104A (en) | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO 2.2.2 OCT - 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. | |
| UY26177A1 (en) | POLYMORPHOS OF A AZOBICICLO CITRATE (2.2.2) OCT-3- CRYSTALLINE ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS. | |
| TR200601092T1 (en) | New oral pharmaceutical formulations containing the active ingredient irbesartan. | |
| AR045997A1 (en) | STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF AZETIDINE | |
| ECSP003510A (en) | POLYMORPHOS OF A AZOBICICLO CITRATE (2,2,2) OCT - 3 - CRYSTALLINE ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS | |
| PA8577801A1 (en) | T1249 PEGILATED POLYPEPTIDE | |
| AR005730A1 (en) | FORM OF FANCICLOVIR, PROCEDURE FOR PREPARING IT, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF VIRAL INFECTIONS AND THE USE OF SUCH FORM -FANCICLOVIR MONOIDRATE. | |
| DE50311479D1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS | |
| PE20040066A1 (en) | NEW FORMULATION FOR PARENTERAL ADMINISTRATION OF A Na CANAL BLOCKER | |
| ECSP993181A (en) | PROCEDURE FOR THE PREPARATION OF A HIGH PURITY COMPOSITION OF (7ALFA, 17ALFA) - 17 - HIDROXI-7-19-NOR-17- PREGN-5 (10) -EN -20-IN-3-ONA |